Although intermittent PTH (1–34) administration expands haematopoietic stem cells30–32, persistent PTH elevation in CKD patients might decrease haematopoietic stem cells due to exhaustion in a manner similar to the sulfonylurea-induced exhaustion of insulin secretion that occurs during diabetes treatment33. This evidence concerns the gene PTH and chronic kidney disease.